NCT02950922 - Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis | Biotech Hunter

Enrollment

157

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 3, 2017

Study Completion Date

July 3, 2017

Conditions

Atopic Dermatitis

Interventions

DRUG

RVT-501 0.2% ointment

DRUG

RVT-501 0.5% ointment

OTHER

Vehicle ointment

Placebo comparator

Trial Locations (20)

17022

Dermavant Investigator Site, Hershey

23502

Dermavant Investigator Site, Norfolk

40202

Dermavant Investigator Site, Louisville

40217

Dermavant Investigator Site, Louisville

75230

Dermavant Investigational Site, Dallas

77004

Dermavant Investigator Site, Houston

77030

Dermavant Investigator Site, Houston

78213

Dermavant Investigator Site, San Antonio

90045

Dermavant Investigator Site, Los Angeles

92123

Dermavant Investigator Site, San Diego

93405

Dermavant Investigator Site, San Luis Obispo

94538

Dermavant Investigator Site, Fremont

97223

Dermavant Investigator Site, Portland

97239

Dermavant Investigator Site, Portland

08009

Dermavant Investigator Site, Berlin

02919

Dermavant Investigator Site, Johnston

Unknown

Surrey

Dermavant Investigator Site, Richmond

Dermavant Investigator Site, Waterloo

Dermavant Investigational Site, Montreal